VEEV — Veeva Systems Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual income statement for Veeva Systems, fiscal year end - January 31st, USD millions except per share, conversion factor applied.

	2022 January 31st	2023 January 31st	2024 January 31st	2025 January 31st	2026 January 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	PRESS
Standards:	USG	USG	USG	USG	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,851	2,155	2,364	2,747	3,195
Cost of Revenue
Gross Profit	1,347	1,546	1,686	2,047	2,413
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	1,345	1,696	1,934	2,055	2,279
Operating Profit	505	459	429	691	916
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	512	509	588	919	1,195
Provision for Income Taxes
Net Income After Taxes	427	488	526	714	909
Net Income Before Extraordinary Items
Net Income	427	488	526	714	909
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	490	553	569	714	909
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	3.02	3.41	4.38	4.35	6.07